Source-grounded facts extracted from Marpai, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Marpai, Inc. incurred loan of $250,000 with Damien Lamendola at 12.0% per annum maturing May 10, 2026.
“On March 9, 2026, Marpai Inc. (the “Company”) issued a promissory note (the “Note”) in the principal amount of $250,000 to Damien Lamendola, the Company’s Chief Executive Officer (the “Holder”). The Note accrues interest at a rate of 12.0% per annum (or the maximum amount of interest allowed under the laws of the State of New York, whichever is less) until the Note is repaid in full.”
Marpai, Inc. incurred loan of $410,000 with Damien Lamendola at 12.0% per annum maturing April 11, 2026.
“On February 12, 2026, Marpai Inc. (the “Company”) issued a promissory note (the “Note”) in the principal amount of $410,000 to Damien Lamendola, the Company’s Chief Executive Officer (the “Holder”). The Note accrues interest at a rate of 12.0% per annum (or the maximum amount of interest allowed under the laws of the State of New York, whichever is less) until the Note is repaid in full. The Note may be prepaid by the Company, in whole or in part, together with all interest then accrued and any other sums then due and payable to the Holder, at any time, without premium or penalty. All payments of outstanding principal, interest and all other amounts due under the Note are payable by April 11, 2026 to the Holder, or its successors and assigns.”
Marpai, Inc.: Amendment to authorize 2,000,000 shares of blank-check preferred stock (effective 2025-10-17).
“the Company’s Amendment to the Second Amended and Restated Certificate of Incorporation (the “Amended Certificate of Incorporation”) was amended to authorize 2,000,000 shares of preferred stock, which shares shall be “blank-check preferred stock” in one or more series as solely determined by the Company’s board of directors (the “Board”)”
Dallas Scrip was appointed as Chief Operating Officer at Marpai, Inc..
“On May 13, 2025, the Board of Directors of Marpai, Inc. (the “Company”) appointed Dallas Scrip, age 42, as Chief Operating Officer of the Company, effective as of June 2, 2025.”
Mike Dendy resigned as Director at Marpai, Inc..
“On May 12, 2024, Mike Dendy notified the board of directors (the “Board”) of Marpai, Inc. (the “Company”) of his resignation from the Board, effective immediately.”
Marpai, Inc. reported the three months ended March 31, 2024 results: revenue $7.4 million, net income $4.3 million, EPS ($0.46).
“Net revenues were approximately $7.4 million for the three months ended March 31, 2024, down $2.3 million, or 24% lower year over year, compared to the three months ended March 31, 2023.”
Marpai, Inc. shareholders approved Approval of an amendment to the Company’s Certificate of Incorporation to include 2,000,000 shares of preferred stock, which shares shall be "blank-check preferred stock" in one or more series as solely determined by the Board, and to have the voting powers, preferences and relative participation, o at the 2024-05-06 meeting.
“Proposal No. 4 — Approval of an amendment to the Company’s Certificate of Incorporation to include 2,000,000 shares of preferred stock, which shares shall be "blank-check preferred stock" in one or more series as solely determined by the Board, and to have the voting powers, preferences and relative participation, optional and special rights and qualifications, limitations and restrictions thereof as solely determined by the Board.”
Marpai, Inc. shareholders approved Ratification of the appointment by the Audit Committee of the Board of UHY LLP, as the Company’s independent registered public accounting firm of the Company for the fiscal year ending December 31, 2024. at the 2024-05-06 meeting.
“Proposal No. 3 — Ratification of the appointment by the Audit Committee of the Board of UHY LLP, as the Company’s independent registered public accounting firm of the Company for the fiscal year ending December 31, 2024.”
Marpai, Inc. shareholders approved Approval of the Plan at the 2024-05-06 meeting.
“Proposal No. 2 — Approval of the Plan.”
Marpai, Inc. shareholders approved Election of Directors at the 2024-05-06 meeting.
“Proposal No. 1 — Election of Directors The stockholders elected the following individuals as directors of the Company to hold office until the next annual meeting of stockholders or until their successors shall have been duly elected and qualified.”
Marpai, Inc. incurred convertible notes of $11,830,000 with JGB Collateral LLC, as collateral agent at prime interest rate plus 5.75% per annum maturing April 15, 2027.
“the Company agreed to sell to the Purchasers Senior Secured Convertible Debentures (the “Debentures”) in an aggregate principal amount of $11,830,000”
Marpai, Inc. entered into Securities Purchase Agreement with the Purchasers valued at $11,830,000 (effective 2024-04-15).
“On April 15, 2024, Marpai, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with each of the purchasers that are parties thereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”) and JGB Collateral LLC, a Delaware limited liability company, as collateral agent for the Purchasers (the “Agent”).”
Marpai, Inc. reported the year ended December 31, 2023 results: revenue $37.2 million, net income Net loss was $28.8 million, EPS ($4.14).
“Net revenues were $37.2 million for the year ended December 31, 2023, an improvement of $12.8 million, or 52.6% higher year over year compared to the year ended December 31, 2022.”
Marpai, Inc. reported the three months ended December 31, 2023 results: revenue $8.7 million, net income Net loss was $5.0 million, EPS ($0.65).
“Net revenues were $8.7 million for the three months ended December 31, 2023, an improvement of $1.1 million, or 14% higher year over year, for the three months ended December 31, 2022.”
Marpai, Inc. entered into Securities Purchase Agreement with HillCour Investment Fund, LLC valued at $1.65 per share (effective 2024-03-07).
“On March 7, 2024, Marpai Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with HillCour Investment Fund, LLC, an entity controlled by the Company’s Chief Executive Officer, Damien Lamendola, pursuant to which the Company agreed to issue and sell 910,000 shares of its Class A common stock (the “Common Stock”) in a private placement, at a purchase price of $1.65 per share”
Marpai, Inc. reported the fourth quarter and fiscal year 2023 results: revenue approximately $8.7 million.
“expects to hold a webcast to discuss the results on March 27, 2024. Financial Highlights: • Net Revenues o For the fourth quarter of 2023, net revenues were approximately $8.7 million, an improvement of nearly $1.1 million or approximately 14% higher from the fourth quarter of 2022. o Full year 2023 net revenues were approximately $37.2 million, an improvement”
Marpai, Inc. reported the fourth quarter and fiscal year 2023 results: revenue approximately $8.7 million.
“expects to hold a webcast to discuss the results on March 27, 2024. Financial Highlights: • Net Revenues o For the fourth quarter of 2023, net revenues were approximately $8.7 million, an improvement of nearly $1.1 million or approximately 14% higher from the fourth quarter of 2022. o Full year 2023 net revenues were approximately $37.2 million, an improvement”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.